Dr. Jialiu Zeng is an Assistant Professor at the Department of Biomedical and Chemical Engineering at Syracuse University. She obtained her B.Eng. in Biomedical Engineering from the National University of Singapore in 2014 and her Ph.D. in Biomedical Engineering from Boston University in 2020. After completing her Ph.D., she conducted her postdoctoral training at Yale University, School of Medicine, in 2020–2021. Prior to joining Syracuse University, she was a Presidential Postdoctoral Fellow and an Early-Career Investigator at the LKC School of Medicine at Nanyang Technological University (NTU) in 2021–2024. Dr. Zeng’s research focuses on examining the role of insulin resistance and autolysosomal dysfunction in α-synuclein-induced PD and obesity-induced metabolic disorders, including T2D and NAFLD. She specializes in synthesizing novel nanomaterials and developing advanced drug delivery platforms to target metabolic dysfunctions and promote the clearance of toxic protein aggregates in the brain. Her lab is also advancing the development of nanomedicine with the capability to cross the blood–brain barrier (BBB) for brain targeting.